InvestorsHub Logo

Chuckles759

11/23/20 9:59 PM

#130582 RE: PersianLeo #130572

amfAR's Wiki page now has a CytoDyn mention on it.

https://en.m.wikipedia.org/wiki/AmfAR,_The_Foundation_for_AIDS_Research

The amfAR Institute for HIV Cure Research at the University of California, San Francisco began in 2015 as the central facility to achieve their Countdown to a Cure for AIDS by 2020. It began from a $20 million grant to UCSF. Many researchers who receive fellowships and grants from amfAR and ARCHE work at the new facilities at UCSF.[59] Under the Countdown to a Cure for AIDS, amfAR hosts an annual HIV Cure Summit, which aims to hear from voices in the research community on breakthroughs, as well as discuss discoveries that have motivated AIDS research, such as the breakthrough with the Berlin patient, who spurred the countdown in the first place.[56][60] In November 2020, amfAR signed an agreement with CytoDyn Inc. to explore the potential of its CCR-5 antagonist Vyrologix (Leronlimab) to mediate a functional HIV cure. According to Kevin Robert Frost, Chief Executive Officer at amfAR, "demonstrating that Leronlimab can functionally phenocopy CCR5 deficiency and replicate the London and Berlin patients would be a major advancement.”[61]

moneycrew

11/23/20 10:18 PM

#130587 RE: PersianLeo #130572

Ok, so that article was from a week ago, the PR was released today, I'm sure amFAR will update. Did you expect instant modifications to their website?

moneycrew

11/23/20 10:19 PM

#130588 RE: PersianLeo #130572

Furthermore, those patients that they are talking about and stem cell I believe was from a study called " The Belin patient" from 2006 if I recall correctly